United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2012_register executive 2015-10-20 article Notices D09002ee1c7fd85cc D09002ee1c7fd863b United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The meeting of the Blood Products Advisory Committee scheduled for February 29, 2012 is cancelled. This meeting was announced in the Federal Register of January 30, 2012 (77 FR 4567). FDA intends to convene at a future date a public scientific workshop to discuss the evaluation of possible new plasma products manufactured following storage at room temperature for up to 24 hours. 77 FR 7588 https://www.govinfo.gov/app/details/FR-2012-02-13/2012-3199 2012-3199 fr13fe12-75 4160-01-P Docket No. FDA-2012-N-0001 https://www.govinfo.gov/app/details/FR-2012-02-13/2012-3199 https://www.govinfo.gov/content/pkg/FR-2012-02-13/html/2012-3199.htm https://www.govinfo.gov/content/pkg/FR-2012-02-13/pdf/2012-3199.pdf 2 p. 7588 7589 77 FR 7588 Blood Products Advisory Committee; Cancellation; Federal Register Vol. 77, Issue NOTICE 2012-3199 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. FDA-2012-N-0001 4160-01-P 2012-3199 Notice.

The meeting of the Blood Products Advisory Committee scheduled for February 29, 2012 is cancelled. This meeting was announced in the Federal Register of January 30, 2012 (77 FR 4567). FDA intends to convene at a future date a public scientific workshop to discuss the evaluation of possible new plasma products manufactured following storage at room temperature for up to 24 hours.

Bryan Emery or Pearl Muckelvene, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, Contact 1- 301-827-1277 or 1-301-827-1281, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. Meetings: Blood Products Advisory Committee; Cancellation , Vol. 77, no. 29 Office of the Federal Register, National Archives and Records Administration 2012-02-13 continuing daily deposited born digital 583 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2012-02-13 P0b002ee18dbb04d4 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr13fe12 https://www.govinfo.gov/app/details/FR-2012-02-13 https://www.govinfo.gov/content/pkg/FR-2012-02-13/pdf/FR-2012-02-13.pdf https://www.govinfo.gov/content/pkg/FR-2012-02-13/xml/FR-2012-02-13.xml fdlp 7517 8088 DGPO 2015-10-20 2024-06-03 FR-2012-02-13 machine generated eng FR FR-2012-02-13 77 29